Michael David Seckler - 08 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Reporting relationship: Chief Commercial Officer
Issuer ticker: CRMD
Reported as of: 08 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jan 2026, 21:30:02 UTC
Source filing: View source filing
Reporting owner signature: /s/ Beth Zelnick Kaufman, attorney-in-fact

Key filing fact

Michael David Seckler filed Form 4 for CorMedix Inc. (CRMD) on 15 Jan 2026.

Key facts

This page summarizes Michael David Seckler's Form 4 filing for CorMedix Inc. (CRMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jan 2026, 21:30.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002105167 Primary reporting owner

Seckler Michael David

Relationship: Chief Commercial Officer
Address: C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS
Signature: /s/ Beth Zelnick Kaufman, attorney-in-fact
Signature date: 15 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRMD transaction

Common Stock

Award

Transaction value: $0
Shares: +133,156
Change %
Price: $0.000000
Shares after: 133,156
Date: 08 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These Restricted Stock Units were granted on 01/08/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.